Preclinical efficacy and safety studies in several animal species including the canine hemophilia B model have provided the basis for a phase I clinical trial of Coagulin B, an AAV vector ...

We have identified 14 mutations of the factor VIII (F8) gene from a panel of 107 patients with hemophilia A and have characterized these gene defects by restriction analysis, oligonucleotide ...